Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fatma A. F. Ragab"'
Autor:
Shaaban K. Mohamed, Joel T. Mague, Mehmet Akkurt, Abdallah M. Alfayomy, Fatma A. F. Ragab, Mokhtar A. Abd ul-Malik
Publikováno v:
Acta Crystallographica Section E: Crystallographic Communications, Vol 78, Iss 9, Pp 880-884 (2022)
In the title compound, C24H23FN4O4S·0.25H2O, the dihydropyrimidine ring is distinctly non-planar, with the flap C atom deviating by 0.297 (2) Å from the least-squares plane. In the crystal, zigzag chains are formed by N—H...N hydrogen bonds paral
Externí odkaz:
https://doaj.org/article/9417d21d647b4ef895e9588ff9a2ff7e
Autor:
Heba T. Abdel-Mohsen, Mona A. Abdullaziz, Ahmed M. El Kerdawy, Fatma A. F. Ragab, Keith J. Flanagan, Abeer E. E. Mahmoud, Mamdouh M. Ali, Hoda I. El Diwani, Mathias O. Senge
Publikováno v:
Molecules, Vol 25, Iss 4, p 770 (2020)
In this study, a novel series of 1,2-disubstituted benzo[d]imidazoles was rationally designed as VEGFR-2 inhibitors targeting hepatocellular carcinoma. Our design strategy is two-fold; it aimed first at studying the effect of replacing the 5-methylfu
Externí odkaz:
https://doaj.org/article/d5681756020243118eccfbe786f07279
Autor:
Shadia A. Galal, Mohamed A. Omar, Sarah H. M. Khairat, Fatma A. F. Ragab, Sonam Roy, Ahmad Abu Turab Naqvi, Md. Imtaiyaz Hassan, Hoda I. El Diwani
Publikováno v:
Medicinal Chemistry Research. 30:1614-1634
Autor:
Amira S, Abd El-All, Asmaa A, Magd-El-Din, Fatma A F, Ragab, Mahmoud, ElHefnawi, Mohamed M, Abdalla, Shadia A, Galal, Ahmed A, El-Rashedy
Publikováno v:
Archiv der Pharmazie. 348(7)
A newly synthesized series of anticancer compounds comprising thiazolo[3,2-a]pyrimidine derivatives 6a-q bearing a benzimidazole moiety was produced via a one-pot reaction of N-(4-(1H-benzo[d]imidazol-2-yl)phenyl)-2-cyanoacetamide 5 with 2-aminothiaz
Autor:
Ahmed, Temirak, Yasser M, Shaker, Fatma A F, Ragab, Mamdouh M, Ali, Salwa M, Soliman, Jeremie, Mortier, Gerhard, Wolber, Hamed I, Ali, Hoda I, El Diwani
Publikováno v:
Archiv der Pharmazie. 347(4)
The 2-(5-methyl-2-furyl)-1H-benzimidazole moiety has shown promising activity against vascular endothelial growth factor (VEGF)-induced angiogenesis. In part I of this study, we have synthesized new analogs and tested their anti-angiogenic potentials